CEO Remuneration Report FY22

Written By Lee Rochester

Wexford Hayes guide to CEO remuneration for the ASX-listed healthcare and biotechnology sectors is out now. Click on the attached link for some key insights. If interested in a copy please contact us.

CEO Rem Report

Lee Rochester
Previous

ACCPA's Executive Team Formation, Shaping the Future for the Australian Aged Care Sector
Next

Board Remuneration Report FY22